Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
449.53
-5.14 (-1.13%)
At close: Jan 14, 2026, 4:00 PM EST
449.50
-0.03 (-0.01%)
After-hours: Jan 14, 2026, 7:58 PM EST
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
27
Consensus Rating
Buy
Price Target
$501.42
Upside
+11.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jan 12, 2026 |
| UBS | UBS | Strong Buy Initiates $546 → $535 | Strong Buy | Initiates | $546 → $535 | +19.01% | Jan 7, 2026 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $548 | Hold → Buy | Upgrades | $548 | +21.91% | Jan 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $456 → $525 | Buy | Maintains | $456 → $525 | +16.79% | Dec 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $460 → $515 | Buy | Maintains | $460 → $515 | +14.56% | Dec 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $516 → $564 | Buy | Maintains | $516 → $564 | +25.46% | Dec 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $438 → $516 | Hold → Buy | Upgrades | $438 → $516 | +14.79% | Dec 3, 2025 |
| UBS | UBS | Strong Buy Maintains $553 → $546 | Strong Buy | Maintains | $553 → $546 | +21.46% | Nov 7, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $423 → $415 | Hold | Maintains | $423 → $415 | -7.68% | Nov 4, 2025 |
| Barclays | Barclays | Hold Maintains $408 → $414 | Hold | Maintains | $408 → $414 | -7.90% | Nov 4, 2025 |
| Stifel | Stifel | Hold Maintains $455 → $445 | Hold | Maintains | $455 → $445 | -1.01% | Nov 4, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $439 → $438 | Hold | Maintains | $439 → $438 | -2.56% | Oct 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $517 → $530 | Buy | Maintains | $517 → $530 | +17.90% | Oct 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $550 → $575 | Strong Buy | Maintains | $550 → $575 | +27.91% | Oct 2, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $458 → $456 | Hold → Buy | Upgrades | $458 → $456 | +1.44% | Sep 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $510 → $475 | Buy | Maintains | $510 → $475 | +5.67% | Sep 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.